✦ LIBER ✦

A new format of bispecific antibody: highly efficient heterodimerization, expression and tumor cell lysis

✍ Scribed by Zhigang Xie; Ning Guo; Ming Yu; Meiru Hu; Beifen Shen

Book ID: 113716906
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 345 KB
Volume: 296
Category: Article
ISSN: 0022-1759
DOI: 10.1016/j.jim.2004.11.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficient tumor cell lysis by autologous

Efficient tumor cell lysis by autologous, tumor-resident T lymphocytes in primary ovarian cancer samples by an EP-CAM-/CD3-bispecific antibody

✍ Pauline Wimberger; Wei Xiang; Doris Mayr; Joachim Diebold; Torsten Dreier; Patri 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 229 KB

## Abstract The epithelial cell adhesion molecule (Ep‐CAM) is expressed on the surface of most human carcinomas, including ovarian, breast, lung, prostate and colorectal carcinoma. Ep‐CAM was shown to be a valid target for monoclonal antibody‐based therapies. We have investigated whether an Ep‐CAM‐

Combination of rituximab with blinatumom

Combination of rituximab with blinatumomab (MT103/MEDI-538), a T cell-engaging CD19-/CD3-bispecific antibody, for highly efficient lysis of human B lymphoma cells

✍ Sandrine d’Argouges; Sandra Wissing; Christian Brandl; Nadja Prang; Ralf Lutterb 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 815 KB

Bispecific monoclonal antibodies directe

Bispecific monoclonal antibodies directed to CD16 and to a tumor-associated antigen induce target-cell lysis by resting NK cells and by a subset of NK clones

✍ Silvano Ferrini; Ignazia Prigione; Silvia Miotti; Ermanno Ciccone; Claudia Canto 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 716 KB

Potentiation of lysis of leukaemia cells

Potentiation of lysis of leukaemia cells by a bispecific antibody to CD33 and CD16 (FcγRIII) expressed by human natural killer (NK) cells

✍ Lucia M. R. Silla; Jian Chen; Rui-kun Zhong; Theresa L. Whiteside; Edward D. Bal 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 729 KB

A New Format of Single Chain Tri-specifi

A New Format of Single Chain Tri-specific Antibody with Diminished Molecular Size Efficiently Induces Ovarian Tumor Cell Killing

✍ Jing Liu; Qi Zhao; Baofeng Zhao; Julong Cheng; Xiangbin Wang; Liping Song; Zhang 📂 Article 📅 2005 🏛 Springer Netherlands 🌐 English ⚖ 268 KB

Bi20 (fBTA05), a novel trifunctional bis

Bi20 (fBTA05), a novel trifunctional bispecific antibody (anti-CD20 × anti-CD3), mediates efficient killing of B-cell lymphoma cells even with very low CD20 expression levels

✍ Michael Stanglmaier; Margot Faltin; Peter Ruf; Annette Bodenhausen; Petra Schröd 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 312 KB

## Abstract Trifunctional bispecific antibodies can efficiently mediate tumor cell killing by redirecting T cells and immune accessory cells to the tumor cell. Here, we describe the new trifunctional antibody, Bi20 (FBTA05, anti‐CD20 × anti‐CD3), that connects B cells and T cells __via__ its variab